dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet
- RxCUI
- 1433873
- RxNorm name
- dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet
- Display name
- dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet
- Full name
- dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tivicay | DOLUTEGRAVIR SODIUM | ST. MARY'S MEDICAL PARK PHARMACY | 485bc9db-8665-9f5a-e063-6394a90a7921 | 2026-05-22 | Warnings, Adverse reactions | 1433873 |
| Tivicay | DOLUTEGRAVIR SODIUM | ViiV Healthcare Company | 63df5af3-b8ac-4e76-9830-2dbb340af922 | 2025-10-29 | Warnings, Adverse reactions | 1433873 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 63df5af3-b8ac-4e76-9830-2dbb340af922 | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 31 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20251029 |
| 63df5af3-b8ac-4e76-9830-2dbb340af922 | dolutegravir 50 MG Oral Tablet | SCD | 31 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20251029 |
| 63df5af3-b8ac-4e76-9830-2dbb340af922 | dolutegravir 50 MG Oral Tablet | PSN | 31 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20251029 |
| b00132b8-58b1-7533-e053-2995a90a0cf1 | dolutegravir 50 MG Oral Tablet | SCD | 5 | Tivicay 50mg tab | 20240718 |
| b00132b8-58b1-7533-e053-2995a90a0cf1 | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 5 | Tivicay 50mg tab | 20240718 |
| b00132b8-58b1-7533-e053-2995a90a0cf1 | dolutegravir 50 MG Oral Tablet | PSN | 5 | Tivicay 50mg tab | 20240718 |
| 485bc9db-8665-9f5a-e063-6394a90a7921 | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20260522 |
| 485bc9db-8665-9f5a-e063-6394a90a7921 | dolutegravir 50 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20260522 |
| 485bc9db-8665-9f5a-e063-6394a90a7921 | dolutegravir 50 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20260522 |
| 44c4bbcc-fe93-4b4b-ad6a-12f46d2354ec | dolutegravir 50 MG Oral Tablet | PSN | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20230911 |
| 44c4bbcc-fe93-4b4b-ad6a-12f46d2354ec | dolutegravir 50 MG Oral Tablet | SCD | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20230911 |
| 44c4bbcc-fe93-4b4b-ad6a-12f46d2354ec | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 2 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013 | 20230911 |
| 807b0cd2-093c-4353-a4a5-2e1f264616ba | dolutegravir 50 MG (as dolutegravir sodium 52.6 MG) Oral Tablet | SY | 1 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 2013 | 20190124 |
| 807b0cd2-093c-4353-a4a5-2e1f264616ba | dolutegravir 50 MG Oral Tablet | PSN | 1 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 2013 | 20190124 |
| 807b0cd2-093c-4353-a4a5-2e1f264616ba | dolutegravir 50 MG Oral Tablet | SCD | 1 | These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 2013 | 20190124 |